Paclitaxel and Cisplatin is named as a drug or biological intervention in 2 clinical trials in our China trial register, 1 of which is recruiting. Lead sponsors include Shandong Cancer Hospital and Institute (1) and Tianjin Medical University Cancer Institute and Hospital (1). Registered phase: Phase 2. Conditions studied include Endometrial Neoplasms; Neoplasm Recurrence, Local; Neoplasm Metastasis.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06532539 | Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma (ClinicalTrials.gov ↗) Endometrial Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis |
Phase 2 | Recruiting |
| NCT07721103 | Early Response-guided Sequential Radiotherapy After Chemoimmunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ClinicalTrials.gov ↗) Esophageal Squamous Cell Carcinoma (ESCC) |
Phase 2 | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Endometrial Neoplasms | 1 |
| Neoplasm Recurrence, Local | 1 |
| Neoplasm Metastasis | 1 |
| Esophageal Squamous Cell Carcinoma (ESCC) | 1 |
| Lead sponsor | Trials |
|---|---|
| Shandong Cancer Hospital and Institute | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
| Register | Paclitaxel and Cisplatin trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Paclitaxel and Cisplatin works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Paclitaxel and Cisplatin (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.